Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Lotus Eye Hospital And Institute Ltd (LOTUSEYE)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532998 NSE: LOTUSEYE Hospital & Healthcare Services | Small Cap | Lotus Eye Hospital Share Price
₹114.80 -0.80 (-0.69%)
As on 28-Sep'26 16:59
Lotus Eye Hospital And Institute Ltd (LOTUSEYE)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532998 NSE: LOTUSEYE Hospital & Healthcare Services | Small Cap | Lotus Eye Hospital Share Price
₹114.80 -0.80 (-0.69%)
As on 28-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹239 Cr.
Current Price
₹114.8
52-Week Low / High
₹98 / 153
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
98.6
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
8.37%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
40.14%
Pledged shares (%) of Promoter's holding (%)
87.15%
Reserves
-
Equity
₹20.8 Cr.
Face Value
₹10
All Time Low / High
₹4.43 / 153.00
Check Before You Invest
Quality
Not GoodValuation
OvervaluedCheck Valuation charts
Price Trend
Semi Strong
Is Lotus Eye Hospital And Institute Ltd a good quality company?
Lotus Eye Hospital And Institute Ltd is a weak quality company, based on a inconsistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Lotus Eye Hospital And Institute Ltd performance compare with that of its Peers?
Revenue growth of Lotus Eye Hospital And Institute Ltd vs industry peers?
Lotus Eye Hospital And Institute Ltd revenue CAGR is %, compared to the industry median CAGR of 0.97%, indicating slower growth and losing its market share.
Promoter shareholding and pledge status of Lotus Eye Hospital And Institute Ltd?
Promoters hold 40.14% of the Lotus Eye Hospital And Institute Ltd, with 87.15% of their stake pledged, indicating high pledge risk.
Stock return of Lotus Eye Hospital And Institute Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 19.6% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Lotus Eye Hospital And Institute Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 1.1% | 3.7% | 1.7% | 3.3% | 4.1% | 8% | 10.4% | 7.2% | 3.1% | 1.5% | - |
| Value Creation Index ⓘ | -0.9 | -0.7 | -0.9 | -0.8 | -0.7 | -0.4 | -0.3 | -0.5 | -0.8 | NA | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 34 | 38 | 38.4 | 40.6 | 32.4 | 38.9 | 47 | 48.2 | 49.6 | 53.7 | 57 |
| Sales YoY Gr. | - | 12% | 1.1% | 5.5% | -20.2% | 20.2% | 20.9% | 2.5% | 2.8% | 8.4% | - |
| Adj EPS ⓘ | 0.2 | 0.8 | 0.3 | 0.8 | 0.7 | 1.4 | 2 | 1.4 | 0.4 | 0 | 0.1 |
| YoY Gr. | - | 277.3% | -59% | 120.6% | -2.7% | 97.3% | 36.1% | -28.6% | -75% | -88.6% | - |
| BVPS (₹) ⓘ | 24.1 | 24.4 | 24.1 | 24.7 | 25.3 | 26.3 | 27.7 | 28.6 | 28.9 | 28.9 | 29.2 |
| Adj Net Profit ⓘ | 0.5 | 1.7 | 0.7 | 1.6 | 1.5 | 3 | 4.1 | 2.9 | 0.7 | 0.1 | 0 |
| Cash Flow from Ops. ⓘ | 3 | 5.8 | 4.2 | 5 | 2.7 | 4.4 | 4.4 | 5.7 | 2.7 | 3 | - |
| Debt/CF from Ops. ⓘ | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0 | 0 | 0 | 0.2 | 4 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 5.2% | 10.7% | 4.5% | 8.4% | ||||
| Adj EPS ⓘ | -17.3% | -44.1% | -72.7% | -88.6% | ||||
| BVPSⓘ | 2.1% | 2.7% | 1.5% | 0.2% | ||||
| Share Price | 20.4% | 19.6% | 11.5% | -4.8% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 0.9 | 3.4 | 1.4 | 3.1 | 2.9 | 5.6 | 7.3 | 5 | 1.2 | 0.1 | 0.2 |
| Op. Profit Mgn % ⓘ | 9.8 | 11.5 | 8.4 | 9.8 | 11.2 | 15.3 | 16.4 | 13.8 | 7.2 | 6.6 | 8.5 |
| Net Profit Mgn % ⓘ | 1.4 | 4.5 | 1.8 | 3.8 | 4.7 | 7.7 | 8.7 | 6 | 1.5 | 0.2 | 0.3 |
| Debt to Equity ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 | - |
| Working Cap Days ⓘ | 93 | 96 | 92 | 72 | 88 | 76 | 71 | 79 | 80 | 81 | 37 |
| Cash Conv. Cycle ⓘ | -1 | -9 | -7 | -6 | -9 | -12 | -7 | 1 | 7 | 9 | 9 |
Valuation of Lotus Eye Hospital - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 87.15 | 87.15 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Lotus Eye Hospital And Institute Ltd FAQs
The current trading price of Lotus Eye Hospital on 28-Sep-2026 16:59 is ₹114.8.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 27-Sep-2026 the market cap of Lotus Eye Hospital stood at ₹238.7 Cr
The latest P/E ratio of Lotus Eye Hospital as of 27-Sep-2026 is 1,591.6.
The latest P/B ratio of Lotus Eye Hospital as of 27-Sep-2026 is 3.93.
The 52-week high of Lotus Eye Hospital is ₹153.0 and the 52-week low is ₹97.60.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Lotus Eye Hospital is ₹57.25 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Lotus Eye Hospital And Institute Ltd is a below average quality company.
The key valuation ratios of Lotus Eye Hospital And Institute Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Lotus Eye Hospital And Institute Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.
About Lotus Eye Hospital And Institute Ltd
Lotus Eye Care Hospital was originally incorporated as ‘Kalaivani Health Centre Pvt. Ltd.’on March 14,1997 under the Companies Act, 1956 vide Certificate of Incorporation issued by the Registrar of Companies, Tamil Nadu, Coimbatore. The name of the Company was changed to ‘Lotus Eye Care Hospital Pvt. Ltd. on January 23, 2006 and subsequently to ‘Lotus Eye Care Hospital Limited’ upon conversion into Public Limited Company on October 16, 2007 and a fresh certificate of incorporation has been obtained from Registrar of Companies, Tamil Nadu, Coimbatore.
Lotus Eye Care Hospital is a hi-tech super specialty eye care hospital catering its value added service to the society since inception
Lotus is known for its excellence in Ophthalmic services with personalized care. Lotus is committedly pioneering in the technological revolution in eye care and rendering service to thousands of patients from across the globe to see the world better than ever before.
In the year 1998 Lotus introduced Multi Scan Lasik and in the year 2002 Wave front based Esiris Custom Lasik for the first time in India. Lotus was the first Eye Hospital in South East Asia to have performed Epilasik in July 2004. In the year June 2005 Lotus introduced the most advanced technology of Zyoptix Z100 and combined two superior technologies Epilasik and Zyoptix known as Zyoptix Integrated Epilasik to achieve Supervision.
Lotus has a vision of “empowering eyes to illuminate livesâ€. Lotus Eye Care group is marching towards its vision of becoming India’s best Corporate Hospital with branches in strategic locations where quality eye care is in need, and render world class eye care service to the society.
Dr.SK.Sundaramoorthy and his team of ophthalmic experts, who have highly qualified with vast experience in each specialty, render comprehensive eye care to hundreds of patients daily at their state of the art eye hospitals in Coimbatore, Tirupur and Salem in South India.
Services offered by the company:
- Specialty Treatments
- Institute of Optometry
- Community ophthalmology
- Medical Tourism
- Eye Bank
Milestones:
- 1989- Opening of hospital at R.S.Puram, Coimbatore. The same was under management of LVRT from 1992 to 2006.
- 2002- Opening of hospital at Peelamedu, Coimbatore
- 2004 -Opening of hospital at Salem
- 2007- Opening of hospital at Tirupur
Achievements/ recognition:
- Lotus was the first Eye Hospital in South East Asia to have performed Epilasik in July 2004.
- In the year June 2005 Lotus introduced the most advanced technology of Zyoptix Z100 and combined two superior technologies Epilasik and Zyoptix known as Zyoptix Integrated Epilasik to achieve Supervision.
- 2012 - Life Time Achievement Award to Dr.K.Sundramoorthy by The TamilnaduDr.M.G.R.Medical University.
- 2014 - For the sake of Governor Award to Dr.K.Sundramoorthy by Rotary International.
You have 47 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
